GMI Research expects Bridge-to-transplant (BTT) application segment to grow rapidly during the forecast period, growing at a CAGR of 9.5% during 2018–2025 in South Africa

The South Africa Ventricular Assist Device market touched USD XX million by 2025, growing at a CAGR of 11.0% during 2018–2025.

The key factors boosting growth of the market are:
• Increasing number of patients suffering from heart diseases.
• Shortage of heart donors and increase in heart failures.
• Improving healthcare infrastructure in South Africa

Ventricular Assist Device market in South Africa is significantly growing due to rise in transition to minimally invasive surgical procedure from conventional surgeries. Additionally, growing cardiac patient’s pool with heart failures and shortage of heart donors have contributed to the market growth

Left Ventricular Device dominates the market and is expected to do so during the forecast period due to increasing number of left ventricular assist device implantations every year and technological improvements in LVAD implantation procedure. Apart from it the Right Ventricular Device and Biventricular device segment will also see considerable growth rate in the forecast period.

According to GMI Research Bridge-to-transplant application segment held the maximum revenue in 2018 because of increasing patient awareness regarding cardiac diseases, their treatment and devices. Also, shortage of heart donors leads to the alternative method which is installing of VAD in the ventricle. However, the Bride-to-recovery segment is expected to grow in the forecast period due to rise in disposal income and technological advancements in product design.

Key takeaways/key essentials:

  • In 2018, the Bridge-to-transplant application segment held the maximum revenue share in 2018 and will continue to do so in the forecast period.
  • Transcutaneous design type is expected to grow the fastest rate in the forecast period.
  • South Africa is one of the fastest growing economies in the MEA region.

Various notable players operating in South Africa Ventricular Assist Device Market Berlin Heart GmbH, Cardiac Assist, Inc. (LivaNova), HeartWare International, Inc. , Jarvik Heart, Inc., Reliant Heart, Inc., Abbott Healthcare, Sun Medical Technology Research Corp., Syncardia System, Inc., Thoratec Corporation, and Abiomed Inc. among others.

The South Africa Ventricular Assist Device Market has been segmented on the basis of Type, Application, and Design Segmentation. Based on Type, the market comprises of Left Ventricular Device, Right Ventricular Device and Biventricular Device. The Application type includes Bridge-to-transplant (BTT), Bridge-to-recovery (BTR) and Destination Therapy and the Design type includes Implantable Ventricular Assist and Transcutaneous Ventricular Assist Devices

The research report “South Africa Ventricular Assist Device Market” provides in-depth analysis of the Ventricular Assist Device market, in South Africa, based on application type, design type and type for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Ventricular Assist Device Market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, Please Visit: https://www.gmiresearch.com/report/south-africa-ventricular-assist-device-vad-market/

Early buyers will get customization upto 25% on report

Contact Sarah Nash
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com